Biggest News Aggregation in the World
📰 Immune News

Page 32 - Immune News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immune. Real-time updates on events, politics, business and more.

Alpine Immune Sciences, Inc.: Alpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company
Soult Ukpyolsi South Korea Gewinn Nur Mico Convention Center European Renal Association European Hematology Association

MyJournals.org - Science - 'IJMS, Vol. 24, Pages 8928: Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer' (International Journal of Molecular Sciences)

MyJournals.org - Science - IJMS, Vol. 24, Pages 8928: Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer (International Journal of Molecular Sciences)
Generally Recognized

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

SEATTLE, May 12, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to... | May 12, 2023
New York United States Erica Jones Adaptive Biotechnologies Corporation Nasdaq Corporate Communications Biotechnologies Corporation

SAB Biotherapeutics Announces First Publication of Promising Nonclinical Data for SAB-183 Against Pneumonic Plague in the Journal Antibodies

In study conducted for U.S. Army Medical Research Institute, SAB-183 demonstrated strong immune protection and response against Yersinia pestis infection, which causes plague Findings demonstrate... | May 12, 2023
Tom Luke Us Army Medical Research Institute Biotherapeutics Inc Head Of Research Exchange Commission Medical Research Institute

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity, will aid Ariceum's discovery of treatments for solid tumorsAriceum's expertise
United States Bruxelles Capitale Marie Curie Dhaval Patel Pureos Bioventures Life Sciences

"Pathophysiological Effects of Contemporary Lifestyle on Evolutionary-C" by Jim Parker

Polycystic ovary syndrome (PCOS) is increasingly being characterized as an evolutionary mismatch disorder that presents with a complex mixture of metabolic and endocrine symptoms. The Evolutionary Model proposes that PCOS arises from a collection of inherited polymorphisms that have been consistently demonstrated in a variety of ethnic groups and races. In utero developmental programming of susceptible genomic variants are thought to predispose the offspring to develop PCOS. Postnatal exposure t...
Revolutionary Model Endocrine Disrupting Chemicals Insulin Resistance Polycystic Ovary Syndrome
Source: uow.edu.au

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science